Workflow
雅博股份(002323) - 2024 Q3 - 季度财报
YaboYabo(SZ:002323)2024-10-30 10:33

Financial Performance - Revenue for Q3 2024 was ¥67,847,903.38, a decrease of 72.95% compared to the same period last year[1] - Net profit attributable to shareholders was -¥18,918,332.81, representing a decline of 363.93% year-over-year[1] - The company reported a 60.87% decline in operating income for the first nine months of 2024, totaling ¥188,470,946.45[4] - Total operating revenue for Q3 2024 was ¥188,470,946.45, a decrease of 60.8% compared to ¥481,630,172.75 in the same period last year[15] - Net loss for Q3 2024 was ¥64,301,091.95, compared to a net loss of ¥9,455,882.91 in Q3 2023, representing a significant increase in losses[16] - The total comprehensive loss for Q3 2024 was ¥64,306,457.88, compared to a loss of ¥9,532,708.09 in Q3 2023, highlighting the company's challenging financial situation[16] - Basic earnings per share for Q3 2024 were -¥0.0302, compared to -¥0.0044 in Q3 2023, indicating a worsening financial performance[16] Cash Flow - Cash flow from operating activities showed a net outflow of -¥140,401,683.09, a decrease of 329.31% compared to the previous year[5] - Operating cash inflow for the period was CNY 269,340,989.59, a decrease of 45.4% compared to CNY 492,961,408.32 in the previous period[17] - Operating cash outflow totaled CNY 409,742,672.68, down from CNY 525,665,435.94, resulting in a net cash flow from operating activities of CNY -140,401,683.09[17] - The company reported a decrease in cash received from sales of goods and services, totaling CNY 251,336,839.95 compared to CNY 441,892,003.21 in the previous period[17] - Investment activities generated a net cash inflow of ¥13,070,645.13, a significant improvement compared to the previous year[5] - Financing activities resulted in a net cash inflow of ¥73,988,609.32, an increase of 137.99% year-over-year[5] Assets and Liabilities - Total assets at the end of Q3 2024 were ¥1,123,828,982.72, down 11.03% from the end of the previous year[1] - The company's total current assets decreased from 1,038,364,582.01 to 927,305,341.40, a reduction of approximately 10.7%[12] - Cash and cash equivalents decreased significantly from 102,417,863.84 to 32,529,692.74, a decline of about 68.2%[12] - Accounts receivable decreased from 252,725,384.83 to 218,728,470.01, a decrease of approximately 13.4%[12] - The company's long-term equity investments decreased from 56,648,921.15 to 51,786,763.73, a decline of approximately 8.6%[12] - Total liabilities decreased to ¥567,927,070.83 from ¥642,883,685.19, a reduction of about 11.7%[14] - The equity attributable to shareholders of the parent company decreased to ¥556,072,793.34 from ¥620,065,808.55, a decline of approximately 10.3%[14] Shareholder Information - The total number of common shareholders at the end of the reporting period is 57,117, with no preferred shareholders having restored voting rights[6] - The largest shareholder, Shandong Quanxing Technology Co., Ltd., holds 23.47% of shares, amounting to 497,703,136 shares[6] - The company has not identified any related party relationships among the top ten shareholders[7] - The company plans to increase its shareholding by investing between 50 million and 100 million RMB within six months starting from May 31, 2024[8] - As of August 31, 2024, the controlling shareholder has acquired 5,232,360 shares, representing 2.47% of the total share capital, with an investment of 57,659,300 RMB[8] Inventory and Borrowings - Inventory increased significantly by 932.87% to ¥29,975,414.05 due to expanded stock levels[4] - Short-term borrowings rose by 52.55% to ¥144,908,260.44, attributed to increased financing[4] Expenses - Total operating costs for Q3 2024 were ¥252,743,285.26, down 47.9% from ¥486,221,700.61 year-over-year[15] - Research and development expenses for Q3 2024 were ¥12,795,726.08, down 41.0% from ¥21,676,345.43 in the previous year[15] - The company reported a significant increase in financial expenses, totaling ¥6,381,335.84, compared to ¥3,052,015.66 in the same period last year[15]